In collaboration with the Victorian Transplantation and Immunogenetics Service (VTIS) and the Australian Red Cross Blood Service (ARCBS), Kurmis Orthopaedics are pleased to now be able to offer targeted genetic screening for the ‘at risk’ gene combination linked to adverse tissue reactions (including pseudotumours) around metallic orthopaedic joint replacements. While this is not a diagnostic test, the result allows determination of the presence (or absence) of this specific gene for an individual patient. The test requires a specific blood test and can only be ordered by a doctor using the correct request form (see link below).
Please note that this test is not covered by private health insurance or Medicare and there is an associated out-of-pocket expense. Appropriate use of this genetic screening test should be discussed at consultation with Associate Professor Kurmis, or with your trusted general practitioner.